Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Hepatitis E Diagnostic Tests Market: By Test Type, By Product Type By Distribution Channel, and Region Forecast 2019-2030
Hepatitis E Diagnostic Tests Market: By Test Type, By Product Type By Distribution Channel, and Region Forecast 2019-2030
Hepatitis E Diagnostic Tests Market size was valued at US$ 65.23 million in 2023 and is poised to grow at a significant CAGR of 4.5% from 2024-2030. Hepatitis E is caused by hepatitis E virus (HEV). The virus is a single-stranded ribonucleic acid (RNA) genome. The virus has four genotypes. Genotypes 1 and 2 have been found only in humans. Genotype 3 and 4 viruses circulate in several animals without causing any disease and is rarely infect humans. Definitive diagnosis of hepatitis E infection is usually based on the detection of specific IgM antibodies to the virus in a persons blood. The diagnosis of the hepatitis E is usually done by blood test or the stool test. Additional tests include reverse transcriptase polymerase chain reaction (RT-PCR) to detect the hepatitis E virus RNA in blood and/or stool.
Study Period
2025-2031Base Year
2024CAGR
4.5%Largest Market
EuropeFastest Growing Market
North-America
Increase in the prevalence of hepatitis E is the key factor attributing the growth of the Hepatitis E diagnostic tests market. According to the World Health Organization (WHO), approximately 20 million people suffer from Hepatitis E each year, out of which 3.3 million are symptomatic cases and 56 600 hepatitis E-related deaths. The diagnosis of this virus is usually done using various testing kits such as ELISA HEV IgM test kits, ELISA HEV IgG test kits, RT-PCR test kits, and the prevalence of the disease is expected to provide opportunity to the manufacturers. However, the limited awareness among the people regarding the disease is hampering the growth of market. The high cost of the testing kits are likely to hider the growth of the Hepatitis E Diagnosis Market.
Geographically, global hepatitis E diagnostic tests market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific market (Hepatitis E Diagnosis Market) is the dominant market. According to the World Health Organization (WHO), the prevalence of the disease is higher in East and South Asia. The disease is showing a prominent development in the areas where the hygienic conditions are poor and lack of sanitation.
The lack of awareness among the people is anticipated to drive the growth of the market. The incidence of the disease is more in the regions such as Nigeria, Kenya, Uganda, and Morocco. The North America and Europe marketare expected to witness sluggish growth rate over the forecasted period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 65.23 million |
|
Market CAGR |
4.5% |
|
By Test |
|
|
By Product |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global hepatitis e diagnostic tests market size was valued at US$ 65.23 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
Fast-track diagnostics Ltd, Altana Diagnostics GmbH, Beijing Wantai Biological Pharmacy, Mikrogen GmBH, Hoffmann-La Roche Ltd, Biokit S.A, MP Biomedicals LLC, Fortress Diagnostics Ltd.
| 1.Executive Summary |
| 2.Global Hepatitis E Diagnostic Tests Market Introduction |
| 2.1.Global Hepatitis E Diagnostic Tests Market - Taxonomy |
| 2.2.Global Hepatitis E Diagnostic Tests Market - Definitions |
| 2.2.1.Test |
| 2.2.2.Product |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Hepatitis E Diagnostic Tests Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Hepatitis E Diagnostic Tests Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Hepatitis E Diagnostic Tests Market By Test, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. RT-PCR Test |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. ELISA HEV IgM Test |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. ELISA HEV IgG Test |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Hepatitis E Diagnostic Tests Market By Product, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Kits |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Reagents |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Hepatitis E Diagnostic Tests Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Diagnostic Laboratories |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Hepatitis E Diagnostic Tests Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Hepatitis E Diagnostic Tests Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Test Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.RT-PCR Test |
| 9.1.2.ELISA HEV IgM Test |
| 9.1.3.ELISA HEV IgG Test |
| 9.2. Product Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Kits |
| 9.2.2.Reagents |
| 9.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Diagnostic Laboratories |
| 9.3.2.Hospitals |
| 9.3.3.Others |
| 9.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Hepatitis E Diagnostic Tests Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.RT-PCR Test |
| 10.1.2.ELISA HEV IgM Test |
| 10.1.3.ELISA HEV IgG Test |
| 10.2. Product Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Kits |
| 10.2.2.Reagents |
| 10.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Diagnostic Laboratories |
| 10.3.2.Hospitals |
| 10.3.3.Others |
| 10.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Hepatitis E Diagnostic Tests Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.RT-PCR Test |
| 11.1.2.ELISA HEV IgM Test |
| 11.1.3.ELISA HEV IgG Test |
| 11.2. Product Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Kits |
| 11.2.2.Reagents |
| 11.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Diagnostic Laboratories |
| 11.3.2.Hospitals |
| 11.3.3.Others |
| 11.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Hepatitis E Diagnostic Tests Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.RT-PCR Test |
| 12.1.2.ELISA HEV IgM Test |
| 12.1.3.ELISA HEV IgG Test |
| 12.2. Product Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Kits |
| 12.2.2.Reagents |
| 12.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Diagnostic Laboratories |
| 12.3.2.Hospitals |
| 12.3.3.Others |
| 12.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Hepatitis E Diagnostic Tests Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Test Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.RT-PCR Test |
| 13.1.2.ELISA HEV IgM Test |
| 13.1.3.ELISA HEV IgG Test |
| 13.2. Product Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Kits |
| 13.2.2.Reagents |
| 13.3. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Diagnostic Laboratories |
| 13.3.2.Hospitals |
| 13.3.3.Others |
| 13.4. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Fast-track diagnostics Ltd |
| 14.2.2.Altana Diagnostics GmbH |
| 14.2.3.Beijing Wantai Biological Pharmacy |
| 14.2.4.Mikrogen GmBH |
| 14.2.5.Hoffmann-La Roche Ltd |
| 14.2.6.Biokit S.A |
| 14.2.7.MP Biomedicals LLC |
| 14.2.8.Fortress Diagnostics Ltd. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.